interest rising, page-3

It is interesting to compare QRX with Peplin (PLI). PLI are about 9 months away from probable FDA approval. Two weeks ago a takeover offer was made for them at a value of $A345m

QRX have only 75 million shares on issue and are probably 18 months away from possible FDA approval with products that appear to have a far larger market than PLI's.

If QRX are successful they should command a higher valuation than PLI.

Time will tell